tiprankstipranks
Werewolf Therapeutics (HOWL)
NASDAQ:HOWL
US Market

Werewolf Therapeutics (HOWL) Financial Statements

160 Followers

Werewolf Therapeutics Financial Overview

Werewolf Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.093; its P/E ratio is -2.49; Werewolf Therapeutics is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.38. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-$ 5.90M-$ 400.00K$ 350.00K
Gross Profit---$ 400.00K$ 350.00K
EBIT$ -15.19M$ -8.29M$ -5.10M$ -13.29M$ -13.46M
EBITDA$ -14.35M$ -7.30M-$ -12.47M$ -12.72M
Net Income Common Stockholders$ -16.19M$ -8.29M$ -5.10M$ -11.95M$ 29.95M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 139.20M$ 130.06M$ 137.45M$ 147.87M$ 129.31M
Total Assets$ 177.60M$ 176.39M$ 185.24M$ 195.07M$ 160.25M
Total Debt$ 51.27M$ 52.19M$ 52.82M$ 53.25M$ 14.68M
Net Debt$ -87.93M$ -77.87M$ -84.64M$ -94.62M$ -114.63M
Total Liabilities$ 60.01M$ 63.94M$ 66.65M$ 74.00M$ 37.91M
Stockholders Equity$ 117.59M$ 112.44M$ 118.60M$ 121.07M$ 122.34M
Cash Flow-
Free Cash Flow$ -15.41M$ -7.43M-$ -10.07M$ -12.39M
Operating Cash Flow$ -15.30M$ -7.21M-$ -9.90M$ -11.87M
Investing Cash Flow$ -111.00K$ -221.00K-$ -168.00K$ -518.00K
Financing Cash Flow$ 20.26M$ 41.00K-$ 48.62M$ 1.26M
Currency in USD

Werewolf Therapeutics Earnings and Revenue History

Werewolf Therapeutics Debt to Assets

Werewolf Therapeutics Cash Flow

Werewolf Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis